Nevro Corp at Bank of America Healthcare Conference Transcript
Up next, we have Nevro. We have Keith Grossman, CEO, Nevro and Keith MacLeod -- sorry, Rod MacLeod, CFO. Welcome to the Bank of America Conference.
Thanks for having us.
Questions & Answers
So I just wanted to look at Q1. Perms were up 2%, trials up 10%, some encouraging signs moving into Q2. How much better was kind of March? And are you seeing some of those same trends continuing into April into May for perms and trials?
We are Q1 started the way Q4 ended, which was pretty heavily impacted by the Omicron spike in the pandemic. So we saw heavily impacted January. First week or 2 maybe of February were impacted as well. And then we saw a lot of improvement in the latter part of February and into March, and we've continued to see that through the month of April.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
